Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?

As clinical trial protocols grow more complex, the way research sites are compensated has a direct impact on cost control, operational efficiency, and data quality. Two dominant payment structures—pay‑by‑visit and pay‑by‑procedure—offer very different tradeoffs. Flat, visit‑based payments provide simplicity and predictability, but they can mask variability in actual work performed and create the risk of overpayment when optional procedures are skipped. Procedure‑level compensation, while more complex to configure, aligns payments to verified clinical activity and data entry, improving transparency and financial accuracy.

Selecting the right approach depends on how a protocol is designed. Trials with optional or variable procedures benefit from tighter alignment between execution and reimbursement, especially when electronic data capture systems can support automated triggers. More standardized protocols, where every visit includes the same required activities, may still perform well under a visit‑based model. Understanding these distinctions helps sponsors and CROs balance administrative burden against cost avoidance, site incentives, and data timeliness.

Explore the full analysis to determine which model best supports your study goals.